Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Geoffrey H. Saft, Owner of California Hyperbaric Equipment Company, Celebrating 8-Years of Hyperbaric Oxygen Equipment Sales
Geoffrey H. Saft, owner of California Hyperbaric Equipment Company, has announced he is now celebrating 8 years of providing clients with the highest quality of service for hyperbaric oxygen chambers and accessories. He is certified in hyperbaric therapy and his training and years of experience... - October 24, 2013 - Hyperbaric Oxygen CA
AveXis-BioLife Licenses Spinal Muscular Atrophy (SMA) Patent Portfolio from Nationwide Children's Hospital and The Ohio State University
BioLife, a synthetic biology platform company soon to be renamed AveXis, has been granted exclusive rights to the spinal muscular atrophy gene therapy program developed at The Research Institute at Nationwide Children’s Hospital and The Ohio State University in Columbus, Ohio. The license... - October 21, 2013 - AveXis Inc.
Creative Biomart Releases New Products in the Middle of Oct.
In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative Biomart
Peter Openshaw, Director at CRI, to Speak at Innate Immunity Meeting, Jan 29-31, 2014, San Diego, CA
Peter Openshaw, Director at the National Heart and Lung Institute will give a presentation at the Inaugural Innate Immunity Conference, January 29-31, 2014 in San Diego, CA. - October 19, 2013 - GTCbio
Microfluidics Startup NanoCellect Adds Strategic Advisors and Nabs Another $700K from the NIH
NanoCellect, (previously called NanoSort) aims to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more affordable and easier to use. Spunout from UCSD in late 2009, NanoCellect has now raised over $3.3M including a new $700K grant to continue developing... - October 19, 2013 - NanoCellect
AveXis BioLife Announce The Research Institute at Nationwide Children’s Hospital Received Fast Track Status for Spinal Muscular Atrophy Treatment
AveXis and BioLife, synthetic biology platform companies, today announced that The Research Institute at Nationwide Children’s Hospital received Fast Track designation from the U.S. Food and Drug Administration for its scAAV9.CB.SMN gene therapy product for the treatment of spinal muscular... - October 18, 2013 - AveXis Inc.
VStock Transfer Congratulates Its Client, Soft Landing Labs, LTD., on Securing DTC Eligibility
Soft Landing Labs, LTD. obtains DTC Eligibility. - October 16, 2013 - Vstock Transfer, LLC
Epitope Diagnostics Launches the Second Generation Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate (ADC) Levels
Epitope Diagnostics has recently launched second-generation ADC kits exclusively for the quantitative measurement of DM1-, MMAE-, and MMAF-ADC level. These kits measure both humanized monoclonal antibody based ADC and mouse monoclonal antibody based ADC. Additional benefits for testing PK samples from mice are utilized by these second generation kits. - October 12, 2013 - Epitope Diagnostics, Inc.
Gonzalo Goicochea, Recently Recognized by America's Registry of Outstanding Professionals
America's Registry of Outstanding Professionals recognized Gonzalo Goicochea of Miami, Florida for his accomplishments in the field of Biometrics. Based on his achievements, he has been selected as Professional of the Year 2013. About Gonzalo Goicochea Gonzalo Goicochea was born in West Palm... - October 11, 2013 - America's Registry of Outstanding Professionals
AsisChem Launches New Streamlined Website with Improved Product Search and E-Commerce Features
AsisChem, the contract medicinal drug and drug discovery and research company co-located in Waltham, Massachusetts and St. Petersburg Russia, announced today the launch of its new website with searchable product profiles and e-commerce shopping functions. The new design of www.asischem.com greatly... - October 08, 2013 - AsisChem
Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference
Dr. Toufigh Gordi will discuss the application of modeling at different stages in the drug development process, October 16th, 2013. - October 08, 2013 - Rosa & Co LLC
Biotech Consultancy Firm Moves Headquarters to Marlborough
Boston Biomedical Associates announces relocation at MassBio Regional Mixer. - October 05, 2013 - Marlborough Economic Development Corporation
Xavier Jacq, of Mission to Speak at 4th Ubiquitin Conference, Feb 20-21, 2014, San Diego, CA
Xavier Jacq, Co-founder and Head of Biology and Screening Activities at Mission Therapeutics, to Give a Presentation at the 4th Ubiquitin Research and Drug Discovery 2014, February 20-21, 2014 in San Diego, CA - October 05, 2013 - GTCbio
Captiva Spine’s Proprietary PivoRod® Articulating Minimally Invasive Spinal Rod Receives New U.S. Patent Allowance From US Patent Office
Captiva Spine, Inc., a medical device organization dedicated to developing and distributing spinal technologies in the US and internationally, announced today that a new U.S. patent has been allowed by the USPTO for Captiva Spine’s Proprietary PivoRod® Articulating Minimally Invasive... - October 03, 2013 - Captiva Spine, Inc
MD Stem Cells Indicates Government Shutdown Will Not Impact SCOTS Eye Stem Cell Treatment Study
MD Stem Cells sees no immediate effect on the SCOTS eye stem cell trial but is monitoring NIH throughout the government shutdown. - October 03, 2013 - MD Stem Cells
Market Insight: Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Frost & Sullivan
New market insight uncovers the latest technology trends and strategic approaches for biopharma CMOs. - October 03, 2013 - Frost & Sullivan
New 2-Way & 3-Way Inert Isolation Valve Ideal for Automated Chemistry Applications
RVA Series Manifold Mount Valves feature small footprint, reduced energy consumption, and low heat generation. Can be used in continuous duty applications. - October 02, 2013 - Clark Solutions
Haruki Hasegawa Speaks on Russell Body Phenotype at Protein Expression Conf., Oct. 24-25, San Diego
Haruki Hasegawa, Principal Scientist of Therapeutic Discovery at Amgen to Speak on Russell Body Phenotype at GTC’s Protein Expression, Purification & Characterization Conference on October 24–25, 2013 in San Diego, CA - October 01, 2013 - GTCbio
Michael Naso, Janssen, to Present at Antibody & Protein Therapeutics Mtg., Oct. 24-25, San Diego
Michael Naso, Associate Director at Janssen R&D, Will Give a Presentation Titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities” at GTC’s Antibody & Protein Therapeutics Conference on October 24–25, 2013 in San Diego, CA - October 01, 2013 - GTCbio
Science Celebrity Geoff Notkin Kicks Off Fall Season with New TV Show
It doesn’t feel like autumn in much of Arizona, but the unrelenting heat hasn’t deterred intrepid TV host and adventurer Geoff Notkin from filming his exciting new TV series, STEM Journals at locations throughout the state. Set to debut its second season on Sunday, October 20 on Cox 7... - September 25, 2013 - Aerolite Meteorites, LLC
Emerge Diagnostics Receives FDA 510(k) Clearance for Wireless Device
Emerge Diagnostics is pleased to announce that it has received the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wireless device, PMRU-S. The new clearance will allow for expansion of the EFA technology. The wireless ability will streamline the assessment process as... - September 23, 2013 - Emerge Diagnostics
Creative Biolabs Designs Novel Techniques to Solve Problems Met in Dimerization of ScFv/Fab
In designing strategies for dimerization of antibody fragments, Creative Biolabs has developed novel techniques to solve tricky issues, such as stability and homogeneity of the dimers, resistance to proteolytic cleavage during in vivo assembly, efficient production of preferably soluble protein,... - September 22, 2013 - Creative Biolabs
Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory
After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart
Jules Hoffmann to Give Plenary Keynote at Immunotherapeutics Summit Jan 29-31, 2014 in San Diego, CA
Jules Hoffmann, Nobel Laureate and Invited Professor at Strasbourg University to Give Plenary Keynote Address at Novel Immunotherapeutics Summit on January 29-31, 2014 in San Diego, CA. - September 20, 2013 - GTCbio
Pamela Ronald, UC Davis to Speak at Innate Immunity Conference, Jan 29-31, 2014, San Diego, CA
Pamela Ronald, Professor and Director of the Laboratory for Crop Genetics Innovation and Scientific Literacy from the University of California, Davis, to Give a Featured Presentation at the Inaugural Innate Immunity Conference 2014, January 29-31, 2014 in San Diego, CA. - September 20, 2013 - GTCbio
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.
NIH Awards Advaita $2.0M for Disease Subtyping and Drug Repurposing Technology Development
The National Institute of General Medical Sciences of the National Institutes of Health issued a Notice of Award granting a Fast-Track Small Business Investigational Research (SBIR) Phase I and Phase II grant of $2.0 million for Advaita Bioinformatics, of Plymouth, Michigan to develop biological... - September 13, 2013 - Advaita
International Polymer Solutions Launches New Website
TEQCOM and BECO websites merge to form new International Polymer Solutions site. - September 12, 2013 - International Polymer Solutions Inc.
Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)
Appoints Jay Smith as CEO and Keith Waddell as VP Business Development - September 12, 2013 - Silicon Kinetics
Robert Petrovich, NIEH, to Speak at GTC’s Protein Expression Conf., Oct. 24-25, San Diego
Robert Petrovich, Leader of the Protein Expression Core Facility of the Laboratory of Structural Biology at the National Institute of Environmental Health Sciences to Speak on “Expression and Purification of Proteins in a Budget Limited World” at GTC’s Protein Expression, Purification & Characterization Conference on October 24–25, 2013 in San Diego, CA - September 10, 2013 - GTCbio
Meditech Global, Inc. to Attend the 9th World Meeting on Pharmaceutics, Bio-Pharmaceutics and Pharmaceutical Technology
Meditech Global, Inc., a healthcare and Life Science venture capital company, is pleased to announce they will be attending the 9th World Meeting on Pharmaceutics, Bio-pharmaceutics and Pharmaceutical Technology. - September 10, 2013 - Meditech Global Inc
Creative Biolabs Launches "One-Stop" Phage Display Services
After services expansion, Creative Biolabs is delighted to announce the launch of “one-stop” phage display services for researchers and institutions. - September 08, 2013 - Creative Biolabs
Creative Biolabs Works with UEC for Commercial Phage Display Technology
Creative Biolabs works with UEC for a bioscience and technology program. During the time, Creative Biolabs offers custom phage display construction and screening services by signing a custom service contract for commercial pre-made library. - August 30, 2013 - Creative Biolabs
Creative Biolabs Establishes Solid Platform for DNA Sequencing of Monoclonal Antibodies
Creative BioLabs has established a solid platform for DNA sequencing of both IgG and IgM types of monoclonal antibodies produced by mouse and rat hybridoma cell lines. - August 29, 2013 - Creative Biolabs
Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions
The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart
BIOCAD Company and KOÇAK FARMA Sign a Definitive Agreement on Rituximab
A Definitive Agreement on export of rituximab API produced by CJSC BIOCAD to Turkey was signed on August 13th, 2013 between CJSC BIOCAD and KOÇAK FARMA, a leading Turkish pharmaceutical company with strong presence in the area of oncology. - August 24, 2013 - biocad
Zenalux Research Partnership with Roswell Park Cancer Institute Deploys Zenascope™ PC1 in Interstitial Photodynamic Therapy
Zenalux Biomedical, Inc., a biomedical diagnostics company, is now collaborating with Roswell Park Cancer Institute through the Zenalux Research Partnership program. The partnership has been formed to enable Roswell to use the Zenascope™ PC1 for interstitial photodynamic therapy. The PC1 will... - August 22, 2013 - Zenalux Biomedical, Inc.
International Medical Ventures, Inc. to Attend The 2nd International Conference on Genomics in the Americas
International Medical Ventures, Inc., an early stage life science venture capital company, is pleased to announce they will be attending The 2nd International Conference on Genomics in the Americas. The show is put on by BGI, the largest genomics center in the world and will take place on 12 and 13... - August 21, 2013 - International Medical Ventures Inc
AbboMax, Inc. Announces the Availability of a Portfolio of 23 Stem Cell Research Antibodies
Stem cell research is one of the most fascinating areas of modern biology. AbboMax offers 23 antibodies for stem cell research. Among them antibodies for FOX (Forkhead box) proteins, a family of transcription factors that play important roles in regulating the expression of genes involved in cell growth, proliferation, differentiation, and metabolism. Selected anti- FOXA-1,2,3 and Anti- FOXP-1,2,3 antibodies are validated for use in Western blot. - August 20, 2013 - AbboMax, Inc.
Creative Biomart Releases New Antibody Products—Nanobodies
Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative Biomart
Margaret Karow, Amgen, to Present at Antibody & Protein Therapeutics Mtg., Oct. 24-25, San Diego
Margaret Karow, Executive Director of Biologics Optimization at Amgen, will give a featured presentation titled “Evolution of Antibody Engineering and Assessment” at GTC’s Antibody & Protein Therapeutics Conference on October 24–25, 2013 in San Diego, CA. The antibody... - August 18, 2013 - GTCbio
Genohub Launches Next Generation Sequencing Marketplace
Genohub announced the launch of their online market for next generation sequencing services today. - August 17, 2013 - Genohub
Experts from Creative Biomart Share the Experience on Using Elisa Kits to Improve the Precision of an Assay
There are some issues that researchers might meet in the process of using ELISA Kits. In order to help improve the precision of an assay, Creative Biomart (http://www.creativebiomart.net/) experts concluded the following tips for reference. - August 14, 2013 - Creative Biomart
Joan Block of the Hepatitis B Foundation Honored by Viral Hepatitis Action Coalition of the Centers for Disease Control Foundation
Bucks County executive honored for national advocacy on behalf of healthcare workers and medical students fighting against discrimination. - August 10, 2013 - Hepatitis B Foundation
Stephan Grant to Speak at Protein Kinases Drug Design Oct 23-25, 2013 – San Diego
Stephan Grant, Senior Director of Oncology Research Unit and Head of Biochemistry & Primary Screening, To Give a Featured Presentation at the 2nd Protein Kinases & Drug Design Conference (Oct 23-25, 2013 in San Diego). - August 10, 2013 - GTCbio
AdvantaPure(R) to Feature the Benefits of Its Molded Components, Single Use Products and Process Hoses at Fall Shows; Includes Events in the U.S., Switzerland and China
High purity tubing and single use systems manufacturer AdvantaPure will exhibit at several upcoming trade shows. The company’s products are made for pharmaceutical, bioprocess and other clean applications and meet many industry standards. Events include the BioProcess International Conference in Boston; ILMAC in Basel, Switzerland; and China-Pharm in Shanghai. Other regional shows on the east coast of the U.S. will also be covered. - August 08, 2013 - NewAge Industries, Inc.
Frost & Sullivan Market Insight: The Biobanking Community to Increasingly Require Innovative Products in Bio-Storage Applications
Long-term storage of clinical samples will be critical to the growth of biobanking - August 03, 2013 - Frost & Sullivan
Biotech Company and Craft Beer Association Partner to Advance Craft Beer Education
San Antonio’s newest biotech company, Alamo Yeast Labs, and local craft beer association, the San Antonio Cerveceros, have partnered to create a unique craft beer experience called: Brewatory. Brewatory is a taproom, laboratory and educational center dedicated to educating craft beer enthusiasts about the science behind brewing. - July 30, 2013 - Brewatory
New Company Formed to Focus on New Technology for Disease Treatment
AveXis Inc. (avexisinc.com) announced its formation as a company focused on research and development of technology specifically for disease treatment. A synthetic biology platform company, AveXis has, at its core, a desire to establish unique industry alliances which will bring innovative... - July 27, 2013 - AveXis Inc.
Creative Biolabs Expands Custom Immunoassay Kits for Quantitative Detection
Corresponding to markets needs, Creative Biolabs decides to expand its original custom immunoassay development services. - July 26, 2013 - Creative Biolabs